Skip to main content
Caplight Logo









DawaDose

DawaDose

Private
AmmanHealthcare & Life Scienceshttps://dawadose.com

Last Round

Pre Seed

Sep 10, 2025

Company Overview

DawaDose operates in Healthcare & Life Sciences and is based in Amman. Its latest recorded funding round was a Pre Seed round in September 2025.

DawaDose is a digital pharmacy platform based in Jordan that provides an online marketplace for pharmaceutical products and a B2B platform connecting doctors and pharmacies.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, E-commerce, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

DawaDose Comparables

Compare DawaDose with similar companies based on industry and business-model similarity.

DawaDose comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dawatech
84%
Aumet
78%
Chefaa
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

DawaDose Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 10, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Rushdi Abdalghani

CEO and Founder | E-Pharma B2C & B2B Innovator

Founding Team

Lina Asfour

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Monthly visitors increased 44% MoM, reaching 327.1K.

  • Nov 7, 2025

    Monthly visitors increased 148% MoM, reaching 227.9K.

Book a demo to see all signals

For institutional investors. Book with your work email.

DawaDose Filings

Explore SEC and related filing metadata, where available.

DawaDose filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about DawaDose's valuation, stock price, and market status.

Is DawaDose a public or private company?

DawaDose is a private company.

What is the current stock price of DawaDose?

DawaDose is a private company, so its shares have no public market price. Caplight tracks DawaDose's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is DawaDose worth (valuation)?

Valuation information for DawaDose is not publicly available.

Can I buy DawaDose stock?

DawaDose shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was DawaDose's last funding round?

DawaDose's most recent funding round was Pre Seed on September 10, 2025.

Who are the main investors in DawaDose?

Investor information for DawaDose is not publicly disclosed.

Will DawaDose IPO soon?

No public IPO plans have been announced for DawaDose.

How can I track DawaDose secondary market activity?

Caplight tracks bids, offers, and trades in DawaDose's shares on secondary markets.

Firmographic Details

HeadquartersAmman
Employee Range6
Year Founded2019
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?